The nurse is interviewing a new patient with diabetes who takes rosiglitazone (Avandia). Which information would the nurse anticipate resulting in the health care provider discontinuing the medication?

Rationale: A. The patient has chest pressure when walking: Rosiglitazone is associated with an increased risk of myocardial ischemia and heart failure. Chest pressure with exertion suggests possible angina, making continuation of this medication unsafe and requiring discontinuation. B. The patient's blood pressure is 154/92: Hypertension requires management, but it is not a direct contraindication for rosiglitazone. While blood pressure control is important in diabetes, this finding alone does not mandate stopping the drug. C. The patient's blood glucose is 86 mg/dL: This is a normal fasting glucose level and indicates that diabetes is currently well controlled. It does not necessitate discontinuing rosiglitazone. D. The patient reports a history of emphysema: Chronic lung disease is not directly affected by rosiglitazone use. While comorbidities require monitoring, emphysema is not a contraindication for the drug.